Safety and efficacy of different initial doses of lurasidone in the schizophrenia treatment: A multi-center, randomized, open-label study
Initial doses of 40 mg/day and 80 mg/day lurasidone are safe and effective for acute schizophrenia, with no significant increase in AEs-related discontinuation rate at the higher dose.
Authors
- Qi Wu (ORCID: https://orcid.org/0000-0001-9879-5056)
- Zhifen Liu (ORCID: https://orcid.org/0000-0003-0782-4195)
- Tiebang Liu
- Xin Yu (ORCID: https://orcid.org/0000-0003-3760-2315)
- Dengtang Liu (ORCID: https://orcid.org/0000-0002-0813-6848)
- Mincai Qian
- Yu-Ping Ning
- Qi Liu (ORCID: https://orcid.org/0000-0002-8485-3582)
- Mingli Li (ORCID: https://orcid.org/0000-0002-0818-4460)
- Fang Dong (ORCID: https://orcid.org/0000-0001-8478-433X)
- Tao Li (ORCID: https://orcid.org/0000-0003-3079-481X)
- Xiaoping Wang
Institutions
- Shanghai Jiao Tong University (CN)
- Sichuan University (CN)
- Shanghai Mental Health Center (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- World Journal of Psychiatry
- Published
- 2025-09-26
- DOI
- https://doi.org/10.5498/wjp.v15.i10.110968
- Citations
- 2
- Primary Topic
- Attention Deficit Hyperactivity Disorder
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- Peking University